Robert Carson

The plaintiffs appealed the dismissal of their motion to certify a class action against Facebook for allegedly making users' data available to third-party applications without consent.

The Divisional Court upheld the motion judge's findings that the proposed common issues regarding breach of contract and disgorgement were overly broad and required individual inquiries, and that a class proceeding was not the preferable procedure given the lack of evidence of compensable loss.

The appeal was dismissed.

Meta brought a motion to dismiss or permanently stay Torstar's application, arguing that the dispute should be litigated in California pursuant to forum selection clauses in their News Innovation Agreement.

The court found that the forum selection clauses in Meta's Terms of Service and Commercial Terms applied to users of Meta's products, not to partners licensing content to Meta, and were therefore unclear and inapplicable.

Furthermore, the court held that even if the clauses applied, Torstar demonstrated strong cause not to enforce them, as the dispute involved the interpretation of the federal Online News Act and implicated Canadian public policy and constitutional values regarding freedom of the press.

This is a continued certification motion in a class action alleging that the defendant misused class members' data by making it available to third parties without consent.

The court declined to certify the proceeding on multiple grounds: the proposed class definition was not workable, as it required individual inquiries to develop a Master Class List and was both under-inclusive and over-inclusive; the nominal damages issue could not be certified as a common issue because individual issues were woven into its determination; the proceeding was not the preferable procedure given the absence of evidence of compensable loss and the availability of regulatory proceedings; and the litigation plan was unworkable given the size of the class and the numerous individual inquiries required.

The defendant was awarded costs of $500,000 all-inclusive.

The plaintiffs brought a motion to certify a class action against Facebook, alleging the unauthorized sharing of user data with third-party apps.

The court struck the claims for breach of confidence and breaches of the privacy statutes of British Columbia, Manitoba, and Newfoundland and Labrador, but found the pleadings disclosed causes of action for breach of contract, intrusion upon seclusion, disgorgement, and breach of the Saskatchewan Privacy Act.

The court excluded the plaintiffs' proposed expert evidence but admitted various documentary exhibits.

While the court approved several common issues, it found others required individual inquiries and adjourned the motion to allow the plaintiffs to propose a revised class definition and litigation plan.

The appellants sought to certify a class proceeding against pharmaceutical companies for negligently manufacturing valsartan, alleging contamination with NDMA and NDEA, which are potential carcinogens.

The claim was for damages related to an increased risk of cancer, costs of medical services and monitoring, refunds for drugs, and psychological damages.

The motion judge dismissed the certification, finding no viable cause of action based on concrete injury.

The Court of Appeal dismissed the appeal, affirming that claims for genotoxic injury (molecular changes without perceptible effect), psychological harm (not meeting the 'serious and prolonged' or 'ordinary fortitude' thresholds), and pure economic loss (as the product was discarded and not imminently dangerous) were not compensable in tort.

The court also upheld the dismissal of claims for battery, consumer protection breaches, Competition Act breaches, and unjust enrichment, concluding that the pleadings did not disclose viable causes of action or meet commonality criteria for certification.

The plaintiff brought a proposed class action against numerous pharmaceutical manufacturers and distributors regarding the marketing and sale of opioids in Canada.

The defendants moved to strike the statement of claim for failing to disclose a reasonable cause of action, and one defendant, Pro Doc Limitée, moved to dismiss the action against it for lack of jurisdiction.

The court granted Pro Doc's jurisdiction motion, finding no real and substantial connection to Ontario.

The court struck the claims against the distributor defendants without leave to amend, finding no viable cause of action.

The court found that while there were viable causes of action against the manufacturer defendants for breach of the Competition Act, negligent misrepresentation, fraudulent misrepresentation, and failure to warn, the plaintiff's pleading was defective.

The court struck the claims against the manufacturer defendants with leave to amend to join representative plaintiffs for each defendant group and to comply with the rules of pleading.

Three law firms brought competing carriage motions to represent a class of shareholders of Canopy Growth Corporation in a securities misrepresentation class action.

The court evaluated the competing claims under s. 13.1(4) of the Class Proceedings Act, 1992.

The court granted carriage to the Dziedziejko action, finding that its longer class period, which included thousands of additional shareholders based on prior financial misrepresentations, better served the goals of access to justice and behaviour modification without sacrificing efficiency.

The competing Leonard and Twidale actions were stayed.

The plaintiff, self-represented, brought a claim against the defendants concerning the 2008 acquisition of Aurelian Resources Inc. by Kinross Gold Corporation, alleging conspiracy, share price manipulation, wrongful acquisition of shares, and concealment.

The defendants moved to strike the statement of claim for disclosing no reasonable cause of action, being scandalous/frivolous/vexatious/abuse of process, and being time-barred.

The court struck the claim in its entirety for failing to disclose a reasonable cause of action due to lack of material facts and proper pleading of elements.

Claims arising directly from the 2008 acquisition were also struck as time-barred.

However, the court granted leave to amend the non-time-barred portions of the claim, acknowledging the plaintiff's self-represented status and misunderstanding of pleading rules.

The plaintiff, Dr. Darryl Gebien, sought court approval for a Third-Party Funding Agreement with Omni Bridgeway Ltd. for a proposed class action against numerous pharmaceutical companies regarding the opioid crisis.

Several defendants objected to specific provisions of the agreement, including those related to amendments, assignments, attornment, costs enforcement, termination procedures, accrued costs, and confidentiality.

The court found that while the agreement generally met the requirements for approval, several of the defendants' objections, particularly concerning comprehensive attornment by Omni Bridgeway Ltd. and the broad confidentiality provisions, were "genuinely meaningful" and required resolution.

The motion for approval was adjourned to allow the parties to address these issues, with the court emphasizing that it is not its role to draft the agreement.

The plaintiffs brought a consent motion in writing to approve the dismissal of a putative class proceeding against Facebook and Google on a without costs basis.

The action alleged that Facebook scraped call and text logs from users of the Messenger app on Android devices.

Following the denial of certification in a parallel British Columbia action, the representative plaintiffs no longer wished to proceed due to the risk of adverse costs.

The court approved the dismissal, finding it was not brought for an improper purpose, no private benefit was received to the detriment of class members, and notice to the class was unnecessary.

The plaintiff, an investor in a mining company, brought a motion for leave to commence a secondary market misrepresentation claim under the Securities Act and a motion to certify a class action under the Class Proceedings Act.

The plaintiff alleged that the defendants failed to disclose material facts about the viability of a gold mine in their prospectuses, which were later revealed in a press release, causing a drop in share price.

The court dismissed both motions, finding that the plaintiff failed to provide expert geological evidence to explain the technical mining disclosures and establish that the alleged omissions were known or knowable at the time the prospectuses were issued.

Without such evidence, there was no reasonable possibility of success for the statutory claim and no basis in fact for the class action common issues.

The plaintiffs sought to certify a class action against the defendant pharmaceutical companies for manufacturing and distributing valsartan contaminated with NDMA and NDEA, which are probable human carcinogens.

The plaintiffs claimed damages for psychological harm and pure economic losses (medical bills, medical monitoring, refunds, and wasted pills) arising from the increased risk of being diagnosed with cancer, but explicitly did not claim damages for actually developing cancer.

The court dismissed the certification motion, finding that the law does not recognize a cause of action for the mere creation of risk or for pure economic loss from shoddy but not imminently dangerous goods, and therefore the claims failed to satisfy the cause of action, common issues, and preferable procedure criteria.

The appellant appealed the dismissal of her motion for certification of a class proceeding arising from a data breach involving the respondents and Cambridge Analytica.

The motion judge had denied certification on the basis that there was no evidence that Canadian users' data had actually been shared with Cambridge Analytica, failing the common issues requirement under the Class Proceedings Act.

The Divisional Court dismissed the appeal, finding that the motion judge properly applied the certification test, did not require the appellant to prove loss at the certification stage, and made no palpable and overriding error in his assessment of the evidence or interpretation of the carriage orders.

The court held an initial case conference and issued a timetable on consent for the plaintiff's upcoming motion for leave under Part XXIII.1 of the Securities Act and certification under section 5(1) of the Class Proceedings Act.

The plaintiffs brought a motion for court approval of four settlements totaling over $25 million with TD, RBC, Credit Suisse, and Deutsche Bank in a class action alleging price-fixing in the foreign exchange market.

The plaintiffs also sought approval of Class Counsel's fees of approximately $10.2 million.

The court found the settlements to be fair, reasonable, and in the best interests of the class, noting the significant litigation risks and the substantial results achieved.

The court also approved the requested Class Counsel fees, recognizing the risk undertaken and the successful outcome.

The plaintiff sought court approval to dismiss his proposed class action regarding the recalled drug Valsartan.

Following a carriage agreement with another class action and discovering that one defendant did not manufacture the active ingredient, the plaintiff sought to dismiss the action against all defendants without costs.

The court approved the dismissal under section 29 of the Class Proceedings Act, 1992, finding no prejudice to putative class members as other actions were proceeding across Canada.

The plaintiffs brought a motion to certify the action as a class proceeding for settlement purposes against TD, RBC, Credit Suisse, and Deutsche Bank in a case alleging a conspiracy to fix prices in the futures exchange market.

The court found that the criteria for certification under section 5(1) of the Class Proceedings Act, 1992 were met and granted the motion, approving the settlement agreements and the plan of dissemination.

The plaintiff moved to certify a class action against Facebook alleging that the personal data of Canadian users was improperly shared with Cambridge Analytica.

The court dismissed the certification motion because the plaintiff failed to adduce any evidence that Canadian users' data was actually shared with Cambridge Analytica.

The plaintiff's attempts to shift the focus to the unauthorized access by the third-party app developer were precluded by a prior carriage order that granted those claims to a different class action.

Class Counsel brought a motion for approval of a further instalment of fees in an ongoing competition law class action regarding alleged price-fixing in the foreign exchange market.

The plaintiffs had settled with fourteen groups of defendants and the action continued against the remaining non-settling defendants.

The court reviewed the risks undertaken, the results achieved, and the docketed time, finding the requested fees of $6,325,000, plus costs and disbursements, to be fair and reasonable.

The fee request was approved.

The plaintiffs in a class action regarding foreign exchange price fixing brought a motion to amend the Distribution Protocol for the $110 million settlement proceeds.

The proposed amendments included transferring unused funds from the Indirect Claims Fund to the Direct Claims Fund, setting a minimum $1,000 payout for approved Direct Claimants, and removing the requirement to consider compensation received in other jurisdictions.

The court granted the motion, finding the amendments were administrative, imposed no additional burden on the defendants, and fell within the court's broad discretion under section 12 of the Class Proceedings Act, 1992.